Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,43 € ↓ -0,01 (-0,01%)
2026-06-04
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionUmb Bank N A/mo
Latest Disclosed Ownership175,067 shares
Latest Disclosed Value $ 10,617,813
Umb Bank N A/mo reports 1.59% decrease in ownership of BRM / Bristol-Myers Squibb Company

On May 11, 2026 - Umb Bank N A/mo filed a 13F-HR form disclosing ownership of 175,067 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $9,177,012 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 177,904 shares of Bristol-Myers Squibb Company. This represents a change in shares of -1.59% during the quarter. The current value of the position is $8,303,428 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 175,067 -2,837 -1.59 10,618 10.64 0.1336
2026-02-13 2025-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 177,904 -3,357 -1.85 9,596 17.40 0.1276
2025-11-04 2025-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 181,261 -14,863 -7.58 8,175 -9.96 0.1203
2025-07-11 2025-06-30 13F/A-01 BRISTOL-MYERS SQUIBB COM 110122108 196,124 -117,309 -37.43 9,079 -52.51 0.1415
2025-07-10 2025-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 313,433 0 19,116 0.2773
2025-04-14 2025-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 313,433 107,976 52.55 19,116 64.51 0.3150
2025-01-16 2024-12-31 13F BRISTOL-MYRS SQUIB COM 110122108 205,457 131,595 178.16 11,621 204.11 0.1838
2024-10-09 2024-09-30 13F BRISTOL-MYRS SQUIB COM 110122108 73,862 -9,981 -11.90 3,822 9.74 0.0595
2024-07-29 2024-06-30 13F BRISTOL-MYRS SQUIB COM 110122108 83,843 -19,667 -19.00 3,482 -37.97 0.0571
2024-04-26 2024-03-31 13F BRISTOL-MYRS SQUIB COM 110122108 103,510 -12,458 -10.74 5,613 -5.66 0.0889
2024-01-23 2023-12-31 13F BRISTOL-MYRS SQUIB COM 110122108 115,968 -21,688 -15.76 5,950 -25.52 0.0870
2023-10-18 2023-09-30 13F BRISTOL-MYRS SQUIB COM 110122108 137,656 -5,271 -3.69 7,990 -12.59 0.1282
2023-07-25 2023-06-30 13F BRISTOL-MYRS SQUIB COM 110122108 142,927 -3,692 -2.52 9,140 -10.06 0.1387
2023-04-11 2023-03-31 13F BRISTOL-MYRS SQUIB COM 110122108 146,619 -1,706 -1.15 10,162 101,520.00 0.1625
2023-01-10 2022-12-31 13F BRISTOL-MYRS SQUIB COM 110122108 148,325 -5,549 -3.61 11 -99.91 0.1687
2022-10-13 2022-09-30 13F BRISTOL-MYRS SQUIB COM 110122108 153,874 -8,276 -5.10 10,939 -12.39 0.1845
2022-07-20 2022-06-30 13F BRISTOL-MYRS SQUIB COM 110122108 162,150 -4,228 -2.54 12,486 2.77 0.1944
2022-04-22 2022-03-31 13F BRISTOL-MYRS SQUIB COM 110122108 166,378 2,638 1.61 12,150 19.01 0.1608
2022-02-09 2021-12-31 13F BRISTOL-MYRS SQUIB COM 110122108 163,740 25,488 18.44 10,209 24.80 0.1289
2021-10-18 2021-09-30 13F Bristol Myers Squibb COMMON 110122108 138,252 1,063 0.77 8,180 -10.77 0.1840
2021-07-26 2021-06-30 13F Bristol Myers Squibb COMMON 110122108 137,189 -659 -0.48 9,167 5.34 0.2099
2021-04-15 2021-03-31 13F Bristol Myers Squibb COMMON 110122108 137,848 -1,758 -1.26 8,702 0.50 0.2127
2021-02-04 2020-12-31 13F Bristol Myers Squibb COMMON 110122108 139,606 -15,108 -9.77 8,659 -4.81 0.2332
2020-10-16 2020-09-30 13F Bristol Myers Squibb COMMON 110122108 154,714 0 0.00 9,097 0.00 0.2820
2020-07-16 2020-06-30 13F Bristol Myers Squibb COMMON 110122108 154,714 -4,648 -2.92 9,097 2.41 0.2820
2020-05-26 2020-03-31 13F Bristol Myers Squibb COMMON 110122108 159,362 1,706 1.08 8,883 -12.22 0.3183
2020-01-31 2019-12-31 13F Bristol Myers Squibb COMMON 110122108 157,656 16,237 11.48 10,120 41.10 0.2787
2019-10-30 2019-09-30 13F Bristol Myers Squibb COMMON 110122108 141,419 24,920 21.39 7,172 35.76 0.1722
2019-07-30 2019-06-30 13F Bristol Myers Squibb COMMON 110122108 116,499 36,610 45.83 5,283 38.59 0.1297
2019-04-30 2019-03-31 13F Bristol Myers Squibb COMMON 110122108 79,889 -6,214 -7.22 3,812 -14.83 0.1162
2019-01-24 2018-12-31 13F Bristol Myers Squibb COMMON 110122108 86,103 -754 -0.87 4,476 -16.99 0.1367
2018-10-22 2018-09-30 13F Bristol Myers Squibb COMMON 110122108 86,857 -1,229 -1.40 5,392 10.61 0.1602
2018-07-31 2018-06-30 13F Bristol Myers Squibb COMMON 110122108 88,086 -24,139 -21.51 4,875 -31.33 0.1548
2018-04-25 2018-03-31 13F Bristol Myers Squibb COMMON 110122108 112,225 -19,032 -14.50 7,099 -11.74 0.2293
2018-01-22 2017-12-31 13F Bristol Myers Squibb COMMON 110122108 131,257 -1,842 -1.38 8,043 -5.19 0.2622
2017-10-11 2017-09-30 13F Bristol Myers Squibb COMMON 110122108 133,099 -18,046 -11.94 8,483 0.72 0.2917
2017-08-02 2017-06-30 13F Bristol Myers Squibb COMMON 110122108 151,145 -171,942 -53.22 8,422 -52.06 0.2948
2017-04-24 2017-03-31 13F Bristol Myers Squibb COMMON 110122108 323,087 147,217 83.71 17,569 70.95 0.6146
2017-01-18 2016-12-31 13F Bristol Myers Squibb COMMON 110122108 175,870 -5,688 -3.13 10,277 4.97 0.3783
2016-10-28 2016-09-30 13F Bristol Myers Squibb COMMON 110122108 181,558 -20,641 -10.21 9,790 -34.17 0.3944
2016-07-26 2016-06-30 13F Bristol Myers Squibb COMMON 110122108 202,199 -5,794 -2.79 14,872 11.94 0.6258
2016-04-20 2016-03-31 13F Bristol Myers Squibb COMMON 110122108 207,993 -8,837 -4.08 13,286 -10.93 0.5664
2016-01-19 2015-12-31 13F Bristol Myers Squibb COMMON 110122108 216,830 -1,724 -0.79 14,916 15.29 0.6495
2015-10-28 2015-09-30 13F Bristol Myers Squibb COMMON 110122108 218,554 707 0.32 12,938 -10.75 0.7600
2015-07-20 2015-06-30 13F Bristol Myers Squibb COMMON 110122108 217,847 23,533 12.11 14,496 15.65 0.6639
2015-04-17 2015-03-31 13F Bristol Myers Squibb COMMON 110122108 194,314 41,306 27.00 12,534 38.77 0.5652
2015-01-23 2014-12-31 13F Bristol Myers Squibb COMMON 110122108 153,008 -4,484 -2.85 9,032 12.05 0.4040
2014-10-21 2014-09-30 13F Bristol Myers Squibb COMMON 110122108 157,492 -74,535 -32.12 8,061 -28.38 0.3933
2014-07-18 2014-06-30 13F Bristol Myers Squibb COMMON 110122108 232,027 -110,204 -32.20 11,255 -36.69 0.5345
2014-04-30 2014-03-31 13F Bristol Myers Squibb COMMON 110122108 342,231 17,065 5.25 17,778 2.86 0.9957
2014-02-05 2013-12-31 13F Bristol Myers Squibb COMMON 110122108 325,166 -3,559 -1.08 17,283 13.61 0.9481
2013-11-05 2013-09-30 13F/A-1 Bristol Myers Squibb COMMON 110122108 328,725 -15,317 -4.45 15,213 -1.06 0.8781
2013-11-01 2013-09-30 13F Bristol Myers Squibb COMMON 110122108 344,042 15,376
2013-08-13 2013-06-30 13F Bristol Myers Squibb COMMON 110122108 344,042 344,042 15,376 0.9016
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.